北京市手足口病的病原学研究

1984年北京手、足、口病流行时,采集了18例病人的皮疱液标术。用乳小白鼠作病毒分离,10份阳性,鉴定为阿萨奇A16型病毒(CoxA16)。双份血清标本中和抗体测定结果亦证明为CoxA18感染。     

THE EXPERIMENTAL AND CLINICAL USE OF POLYMYXIN,CHLOROMYCETIN, AND AUREOMYCIN

Polymyxin is an effective antibiotic for the treatment of severe infections produced by Ps. aeruginosa, H. pertussis, H. influenzae, E. coli, and A. aerogenes. Its toxicity to date precludes its general use in infections susceptible to its therapeutic effects.Chloromycetin has been demonstrated to be an effective antibiotic agent for the treatment of rickettsial diseases and typhoid fever. It will undoubtedly prove effective in the treatment of other infections produced by certain Gram-negative micro-organisms and viral agents.Aureomycin has been shown to be an active antibiotic agent against rickettsial diseases, primary atypical pneumonia, acute brucellosis, pneumococcal, streptococcal, and staphylococcal infections, urinary tract infections produced by E. coli, A. aerogenes and Strept. fecalis, certain types of infections of the eye, and in subacute bacterial endocarditis when the infecting agent is Strept. fecalis. Its clinical use in forms of extrapulmonary tuberculosis is in a completely experimental stage. It is not recommended in typhoid fever or in infections due to Ps. aeruginosa or P. vulgaris, and it seems to be ineffective in whooping cough.To date, neither chloromycetin nor aureomycin has shown significant signs of systemic toxicity.     

奥得福尔制剂的药效学研究与临床

对奥得福尔制剂的药效学定量杀菌试验、抗病毒试验及临床应用的结果表明： 得福尔制剂原液,１：１稀释液及１：５稀释液对大肠杆菌、金黄色葡萄球菌和白色念珠菌作用１０ｍｉｎ,杀灭率均可达９９．９％以上;消毒液放置室温下稳定,有机物的存在对杀灭作用有轻度影响,但杀灭率仍可达９９．９％以上;体外抗病毒试验结果表明,该制剂的主要抗病毒功效成分－黄精多糖,对单纯疱疹病毒的空斑抑制率达到１００％;稳定性试验表明,该